microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients

BACKGROUND: Chronic myeloid leukaemia (CML) is a myeloproliferative disorder categorized by malignant transformation of a single stem cell of hematopoietic cells. microRNAs (miRNAs) belong to transcription regulators in hematopoiesis and their altered expression associates with pathogenesis of CML....

Descripción completa

Detalles Bibliográficos
Autores principales: Beg Mirza, Masroor Ali, Guru, Sameer Ahmad, Abdullah, Saleh Mohammed, Rizvi, Aliya, Saxena, Alpana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852824/
https://www.ncbi.nlm.nih.gov/pubmed/31450909
http://dx.doi.org/10.31557/APJCP.2019.20.8.2379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852824/
https://www.ncbi.nlm.nih.gov/pubmed/31450909
http://dx.doi.org/10.31557/APJCP.2019.20.8.2379

Ejemplares similares